Literature DB >> 16373510

Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release.

Mikhail A Gavrilin1, Imad J Bouakl, Nina L Knatz, Michelle D Duncan, Mark W Hall, John S Gunn, Mark D Wewers.   

Abstract

Macrophage responses to Francisella infection have been characterized previously by subdued proinflammatory responses; however, these studies have generally focused on macrophage cell lines or monocyte-derived macrophages. Therefore, we studied the ability of fresh human blood monocytes to engulf and respond to Francisella by using the live vaccine strain variant and Francisella novicida. Because Francisella organisms have been reported to escape from the phagolysosome into the cytosol, we hypothesized that this escape may trigger the activation of caspase-1. Francisella tularensis variants were readily taken up by fresh human CD14(+) monocytes, inducing the release of IL-1beta, as well as IL-8, in a time- and dose-dependent fashion. Importantly, whereas live and dead Escherichia coli, F. novicida, and live vaccine strain, as well as the LPS of E. coli, were able to induce abundant IL-1beta mRNA synthesis and intracellular pro-IL-1beta production, only live Francisella induced enhanced IL-1beta processing and release (51 +/- 10 vs. 7.1 +/- 2.1 ng/ml, for F. novicida vs. E. coli LPS; P = 0.0032). Cytochalasin D blocked the Francisella internalization and the Francisella-induced monocyte IL-1beta processing and release but not that induced by the exogenous stimulus E. coli LPS. Also, killing bacteria did not block uptake but significantly diminished the IL-1beta processing and release that was induced by Francisella. Blocking bacterial escape from the phagosome into the cytosol also decreased IL-1beta but not IL-8 release. These findings demonstrate that Francisella organisms efficiently induce IL-1beta processing and release in fresh monocytes by means of a sensing system that requires the uptake of live bacteria capable of phagosome escape.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373510      PMCID: PMC1324976          DOI: 10.1073/pnas.0504271103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Infectious diseases. An obscure weapon of the cold war edges into the limelight.

Authors:  Gretchen Vogel
Journal:  Science       Date:  2003-10-10       Impact factor: 47.728

Review 2.  Toll-like receptors and their role in experimental models of microbial infection.

Authors:  Salman T Qureshi; R Medzhitov
Journal:  Genes Immun       Date:  2003-03       Impact factor: 2.676

3.  Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.

Authors:  Tara L Kieffer; Siobhan Cowley; Francis E Nano; Karen L Elkins
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

4.  Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties.

Authors:  William O'Connor; Jonathan A Harton; Xinsheng Zhu; Michael W Linhoff; Jenny P-Y Ting
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

5.  An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells.

Authors:  Igor Golovliov; Vladimir Baranov; Zuzana Krocova; Hana Kovarova; Anders Sjöstedt
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

6.  MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival.

Authors:  Crystal M Lauriano; Jeffrey R Barker; Sang-Sun Yoon; Francis E Nano; Bernard P Arulanandam; Daniel J Hassett; Karl E Klose
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

7.  Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112).

Authors:  Evgeny Vinogradov; Wayne J Conlan; John S Gunn; Malcolm B Perry
Journal:  Carbohydr Res       Date:  2004-02-25       Impact factor: 2.104

8.  Francisella tularensis selectively induces proinflammatory changes in endothelial cells.

Authors:  Colin A Forestal; Jorge L Benach; Chateen Carbonara; Jaime K Italo; Tracy J Lisinski; Martha B Furie
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

9.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

Authors:  Laetitia Agostini; Fabio Martinon; Kimberly Burns; Michael F McDermott; Philip N Hawkins; Jürg Tschopp
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

Review 10.  Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases.

Authors:  Fabio Martinon; Jürg Tschopp
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

View more
  128 in total

1.  Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation.

Authors:  Maninjay K Atianand; Ellen B Duffy; Aaloki Shah; Supriya Kar; Meenakshi Malik; Jonathan A Harton
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production.

Authors:  Meagan W Moore; Adriana R Cruz; Carson J LaVake; Amanda L Marzo; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity.

Authors:  Saranya Elavazhagan; Kavin Fatehchand; Vikram Santhanam; Huiqing Fang; Li Ren; Shalini Gautam; Brenda Reader; Xiaokui Mo; Carolyn Cheney; Edward Briercheck; John P Vasilakos; Gregory N Dietsch; Robert M Hershberg; Michael Caligiuri; John C Byrd; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Immunol       Date:  2015-02-09       Impact factor: 5.422

4.  IFNgamma enhances IL-23 production during Francisella infection of human monocytes.

Authors:  Jonathan P Butchar; Kishore V L Parsa; Clay B Marsh; Susheela Tridandapani
Journal:  FEBS Lett       Date:  2008-03-03       Impact factor: 4.124

5.  NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages.

Authors:  Michelle N Brooks; Murugesan V S Rajaram; Abul K Azad; Amal O Amer; Martin A Valdivia-Arenas; Jong-Hwan Park; Gabriel Núñez; Larry S Schlesinger
Journal:  Cell Microbiol       Date:  2010-11-24       Impact factor: 3.715

6.  IgG is transported across the mouse yolk sac independently of FcgammaRIIb.

Authors:  Sudhasri Mohanty; Jonghan Kim; Latha P Ganesan; Gary S Phillips; Keding Hua; David Jarjoura; William L Hayton; John M Robinson; Clark L Anderson
Journal:  J Reprod Immunol       Date:  2009-12-16       Impact factor: 4.054

7.  Effective host response to Francisella tularensis requires functional mast cells.

Authors:  Thomas J Cremer; Susheela Tridandapani
Journal:  Future Microbiol       Date:  2008-10       Impact factor: 3.165

8.  Redundant catalases detoxify phagocyte reactive oxygen and facilitate Histoplasma capsulatum pathogenesis.

Authors:  Eric D Holbrook; Katherine A Smolnycki; Brian H Youseff; Chad A Rappleye
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

9.  The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence.

Authors:  Jeffrey R Barker; Audrey Chong; Tara D Wehrly; Jieh-Juen Yu; Stephen A Rodriguez; Jirong Liu; Jean Celli; Bernard P Arulanandam; Karl E Klose
Journal:  Mol Microbiol       Date:  2009-12       Impact factor: 3.501

10.  Activation of the Intracellular Pattern Recognition Receptor NOD2 Promotes Acute Myeloid Leukemia (AML) Cell Apoptosis and Provides a Survival Advantage in an Animal Model of AML.

Authors:  Nathaniel J Buteyn; Ramasamy Santhanam; Giovanna Merchand-Reyes; Rakesh A Murugesan; Gino M Dettorre; John C Byrd; Anasuya Sarkar; Sumithira Vasu; Bethany L Mundy-Bosse; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Immunol       Date:  2020-02-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.